
A weekly publication by the Bureau of Epidemiology
For January 12, 2001
"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."
--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.
Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Jason Glisson, BS, Epi Editorial Assistant
Bureau of Epidemiology Frequent Contributors:
|
Steven Wiersma, MD, MPH, Deputy State Epidemiologist |
Jodi Baldy, MPH, Biological Scientist IV |
|
Ursula E. Bauer, PhD, Chronic Disease Epidemiologist |
Lisa Conti, DVM, MPH, State Public Health Veterinarian |
Regional Epidemiologists:
|
Dolly Katz, PhD, MPH, SE Florida |
Roger Sanderson, RN, MA, SW Florida |
Carina Blackmore, MS Vet. Med., PhD, NE Florida Carina Blackmore, MS Vet. Med., PhD, |
Zuber Mulla, MSPH, Central Florida Carina Blackmore, MS Vet. Med., PhD, |
Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.
In this issue:
. Current Status of Influenza Vaccine Supply2. Enhanced Surveillance for Superbowl/Gasparilla Festival
3. West Nile Virus Surveillance in Florida
4. Influenza and Respiratory Syncytial Virus Surveillance
Summary Update
5. Epidemiology Teleconference Announcement
6. Epidemiology Grand Rounds for January 30, 2001
7. CDC Announces New Pertussis Guidelines
1. Current Status of Influenza Vaccine Supply
The following CDC statement courtesy of Henry T. Janowski, MPH, Chief, Bureau of Immunization
"As of the end of December 2000, we (CDC) still have available over 6 million doses
of vaccine through our contract with Aventis Pasteur. This vaccine may be purchased by private sector providers for $5 per dose while the public sector cost is $3 per dose. Please share this information widely with colleagues and others who may be able to disseminate it to provider organizations, or individual providers. Any provider needing vaccine can obtain information about ordering by visiting the National Immunization Program's website at:http://www.cdc.gov/nip/flu-vac-supply/flusources.htm
The company will continue taking orders until February 1. We encourage
providers to continue to offer vaccine, especially to individuals with medical conditions which place them at high risk of complications from influenza."
2. Enhanced Surveillance for Superbowl/Gasparilla Festival
Don Ward, Surveillance Section Administrator
The Gasparilla Festival and the Superbowl football game will attract hundreds of thousands of visitors to the Tampa-St. Petersburg area during a period of about two weeks at the end of January and beginning of February. With that influx will come the increased risk for disease outbreaks, whether natural or purposefully initiated. During the critical time period surrounding these events, the Hillsborough and Pinellas County Health Departments, assisted by the Bureau of Epidemiology and the Centers for Disease Control and Prevention will conduct enhanced medical surveillance in five major area hospitals. The county health departments will use two different aberration detection surveillance methods currently being tested by the Florida Department of Health and the CDC. Both of these methods attempt to identify significant variations in patient registrations in hospital emergency rooms. The CDC and DOH staff will provide frequent trend analysis and feedback to the counties. County health department staff will investigate any significant variations identified. In addition to providing actual surveillance related to the events, this program will allow further testing of the aberration algorithms, and will provide insight to the management of "special event" surveillance.
3. West Nile Virus Surveillance in Florida: A Summary of Activity for 2000
Robin Oliveri, Arbovirus Surveillance Coordinator
Bureau of Epidemiology
During 2000, West Nile virus surveillance in Florida included bird mortality, wild avian, sentinel chicken, veterinary, mosquito and human data collection. To introduce and implement this surveillance program a cooperative partnership was defined through the development of an Inter-Agency West Nile Response Plan with the Department of Agriculture and Consumer Services, the Florida Fish and Wildlife Conservation Commission.
Information packets complete with protocols, procedures and contacts were developed and provided to all 67 county health departments, private veterinarians, wildlife rehabilitation centers, zoological parks, wildlife organizations, mosquito control districts, federal agency partners, private medical providers and university centers. Below is a brief summary of the activity conducted during the year 2000 (May – December) for each surveillance area and a summary table of the data collected.
The Florida bird mortality database received a total of 537 reports of dead birds from 43 of Florida’s 67 counties and involving more than 45 different species. 64 birds were submitted for West Nile virus evaluation, of which 56 met the testing criteria (i.e. dead within 24 hours of collection and without decay). All 56 samples were negative for West Nile virus.
Wild avian blood samples have been submitted to the Department of Health laboratory through independent research projects involving various crane species. All 194 samples have tested negative for West Nile virus. The United States Geological Survey (USGS) conducted a large-scale crow bleed in Alachua county (63 sera collected) during December 1999 and January 2000 with negative West Nile results.
The sentinel chicken program included West Nile virus screening on all submitted blood samples. No positive results were found out of 10, 798 individual samples tested. Weekly summaries and maps of flocks bled, including test results, are posted on the Bureau of Epidemiology’s West Nile website at http://www.doh.state.fl.us/disease_ctrl/epi/index.html then choose "health topics" and "arbovirus" or "West Nile virus."
The Department of Defense has submitted weekly mosquito collection information on behalf of Hurlburt AFB, Tyndall AFB, Eglin AFB, MacDill AFB, and Kennedy AFB. Pools were not submitted for West Nile testing. In addition, mosquito collection data have been submitted from the Mosquito/Aquatic Plant Management Division of Lake County.
The DOH laboratories in Tampa and Jacksonville tested more than 50 human samples for arboviruses. In addition, these laboratories provided confirmatory testing of private laboratory results. No case of West Nile virus in a Florida resident has been identified to date.
Table 1. Florida West Nile Virus Surveillance Summary
|
Database |
Total Reports |
Tested |
Positive |
Negative |
|
Bird Mortality |
537 (Crows: 121 Jays: 24 Other: 321) |
Submitted: 64 Tested: 56 |
0 |
56 |
|
Wild Avian Sera |
Cranes: 194 Crows: 63 |
194 63 |
0 (22 EEE) 0 |
194 63 |
|
Sentinel Chicken |
2,389 Flocks |
10, 798 samples |
0 (130 SLE
|
10, 798 |
|
Veterinary (Non- avian) |
78 |
78 |
0 (10 EEE equine)
equine) |
78 |
|
Human |
100 |
100 |
7 Dengue |
93 |
Due to fluctuating winter weather patterns, Florida will continue its West Nile surveillance activities year-round. For more information, please visit the website or contact Robin Oliveri at (850) 245-4444 ext. 2437 or SC 205-4444 ext. 2437.Epidemiology
4. INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUS SURVEILLANCE SUMMARY UPDATE
Carina Blackmore, MS, Vet. Med., PhD, NE Florida
(Week ending December 30, 2000-Week 52)
National report
: See CDC press release from December 29 @ CDC. GOVFlorida: Data from Florida still suggest low levels of influenza activity. Overall, two percent of 9441 patients seeking care by reporting physicians in the influenza sentinel surveillance met the case definition for ILI during week 52.
Higher flu activity than expected for this time of year (>3%) was reported by physicians in Duval, Escambia, Leon, Palm Beach, Pasco and Seminole counties. Influenza B was isolated from patients in Hillsborough county.
Since October 1, 47 influenza isolations have been reported to the state health office: 23 influenza A (H1N1) isolates from Broward, Charlotte, Duval, Escambia, Lake, Leon, Orange and Polk counties, one influenza A (H3N2) from Duval county, 8 untyped influenza A isolates (from Alachua, Columbia, Hillsborough, Orange, Palm Beach and Pinellas counties) and 15 influenza B isolates from Brevard, Broward, Hillsborough, Leon Orange and Volusia counties.
Respiratory syncytial virus (RSV) activity remains high in northeastern, central and the southwestern part of the state where 42.6-51.9% of tested specimens were positive for RSV. Twenty-three percent of RSV specimens tested in the southeast were positive. Eleven hospital laboratories in the state participate in this program.
5. Epidemiology Teleconference Announcement
Melanie Black, LCSW, Professional Training Coordinator, Bureau of Epidemiology,
Epidemiology: How to Investigate and Solve Cases through Strategic Partnerships
Audioconference Series - Prather Building Room 310A . Wednesday, January 17, 2001
2:00 PM -3:00 PM EST
Program Description:
This series of four one-hour audioconferences offered free to Public Health Professionals, show how to develop strategic partnerships among laboratory, epidemiology, and public health program offices in the surveillance and investigation of community disease. You will have the opportunity to learn from others' experiences how to employ the "best practices" for achieving effective programs.
Target Audience:
Public Health Professionals who work with epidemiology and the laboratory are an integral part of their position.
Accreditation:
Continuing education credits will be offered to Public Health Professionals based on one hour of instruction for each audioconference.
Sponsored by:
Delaware Public Health Laboratory, Maryland Department of Health & Mental Hygiene, New Jersey Department of Health & Senior Services, Pennsylvania Department of Health and National Laboratory Training Network
Detection of Unrecognized Outbreaks through Routine Molecular Subtype Surveillance
The usefulness and potential application of continuous molecular subtyping and antimicrobial resistance monitoring as part of a community wide infectious disease surveillance programs will be discussed. Molecular subtype surveillance and susceptibility programs for E. coli 0157:H7, Salmonella typhimurium, Campylobacter jejuni, Neisseria meningitidis, Bordetella pertussis, and Streptococcus pyogenes in Minnesota will be evaluated for scientific merit and cost effectiveness. The unique challenges and prospects facing research into the molecular epidemiology of eukaryotic pathogens such as Cryptosporidium spp, and Giardia lamblia will be reviewed. Finally, a molecular-based approach for detection of outbreaks due to new or rarely recognized pathogens will be described. Following this program, the participants will be able to:
Speaker:
John Besser, M.S.
Clinical Laboratory Manager,
Public Health Laboratory
Minnesota Department of Health
Contact:
If you have any questions or plan to attend this audioconference, please contact Melanie Black, ext. 2448 in the Bureau of Epidemiology or e-mail [Melanie_Black @doh.state.fl.us].
6. Grand Rounds for January 30, 2001
"Varicella Surveillance and Control in Palm Beach County, Florida"
Savita Kumar, MD. MSPH Epidemiologist, Division of Epidemiology & Disease Control, Mario Jacomino, MD., MPH Preventive Medicine Resident, Palm Beach County Health Department
11:00 AM – 12:00 PM EST
Dial-in by 11:10 AM at (850) 487-8587 or SunCom 277-8587
Abstract:
This study was designed to put into practice the recommendations from ACIP; to reduce the incidence of chicken pox in Palm Beach County by educating parents and health care providers; and to establish surveillance for varicella disease cases.
Varicella is not a nationally notifiable disease and surveillance data are limited. A live attenuated varicella virus vaccine was licensed in the United States in 1995. ACIP issued its recommendation for vaccine usage and disease interventions in 1996. The recommendations from ACIP have not been uniformly adopted in Palm Beach County. Each year many cases of Varicella occur in children in Palm Beach County. Currently there is no varicella vaccine requirement for entry to school and day care in Florida.
Additional Information:
Further details regarding the audio-conference call and PowerPoint files will be posted on the Bureau of Epidemiology Intranet web site. Be sure and register on-line for nursing CEU's and contact hours for environmental health professionals (when applicable). Information about upcoming topics and presenters will also be posted in future Epi Updates. If either of these access points is unavailable to you, please e-mail Melanie Black at [Melanie_Black@doh.state.fl.us] or telephone (850) 245-4444 ext. 2448 (SunCom 205-4444 ext. 2448) to request presentation materials.
Important:
While we realize you might not always be able to call in at 11:00 AM, it can be distracting to the speakers and others in the audience when participants dial-in throughout the hour. Please try to call in on time and remember to put your phones on mute so as not to disturb others. Thank you for your cooperation.
Future Grand Rounds Topics:
1. February 27, 2001
Recreational Water-Related Outbreaks
Roberta Hammond, PhD.,Biological Administrator II, Bureau of Environmental Epidemiology
2. March 27, 2001
Arboviral Diseases
Lisa Conti, DVM, MPH, State Public Health Veterinarian
7. CDC Announces New Pertussis Guidelines
Information courtesy of the Council of State and Territorial Epidemiologists
The new "Guidelines for the Control of Pertussis Outbreaks" are on the National Immunization Program (NIP) website:
http://www.cdc.gov/nip/publications/pertussis/guide.htm
8. Weekly Disease Table (Week 1)
| DISEASE |
1998 TO |
1999 TO |
2000 TO |
3 YEAR |
2000 |
2001 TO |
|
Animal Rabies |
5 |
5 |
5 |
5 |
162 |
0 |
|
Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, foodborne |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, infant |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, wound |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, other |
0 |
0 |
0 |
0 |
0 |
0 |
|
Brucellosis |
0 |
0 |
0 |
0 |
2 |
0 |
|
Campylobacteriosis |
3 |
0 |
0 |
1 |
964 |
0 |
|
Ciguatera |
0 |
0 |
0 |
0 |
14 |
0 |
|
Cryptosporidiosis |
0 |
0 |
0 |
0 |
163 |
0 |
|
Cyclosporiasis |
0 |
0 |
0 |
0 |
8 |
0 |
|
Dengue Fever |
0 |
0 |
0 |
0 |
5 |
0 |
|
Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
|
Ehrlichiosis, human |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, chickenpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, herpes |
1 |
0 |
0 |
0.3333 |
4 |
0 |
|
Encephalitis, influenza |
0 |
0 |
0 |
0 |
1 |
0 |
|
Encephalitis, measles |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, mumps |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, other |
0 |
0 |
0 |
0 |
7 |
0 |
|
Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Venezuelan |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Western Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Escherichia Coli 0157:H7 |
0 |
0 |
0 |
0 |
90 |
0 |
|
Escherichia Coli, other |
0 |
0 |
0 |
0 |
15 |
0 |
|
Giardiasis |
1 |
4 |
1 |
2 |
1331 |
0 |
|
H. Influenzae Cellulitis |
0 |
0 |
0 |
0 |
1 |
0 |
|
H. Influenzae Epiglottitis |
0 |
0 |
0 |
0 |
1 |
0 |
|
H. Influenzae Meningitis |
0 |
0 |
0 |
0 |
11 |
0 |
|
H. Influenzae Pneumonia |
0 |
0 |
0 |
0 |
8 |
0 |
|
H. Influenzae Prim.Bacteremia |
0 |
0 |
0 |
0 |
46 |
0 |
|
H. Influenzae Septic Arthritis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hantaviris Infection |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hemolytic Uremic Syndrome |
0 |
0 |
0 |
0 |
13 |
0 |
|
Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hepatitis A |
1 |
1 |
0 |
0.6667 |
550 |
0 |
|
Hepatitis B |
0 |
0 |
0 |
0 |
474 |
0 |
|
Hepatitis B (+HbsAg in pregnant women) |
NR |
0 |
0 |
NR |
432 |
0 |
|
Hepatitis, Perinatal Hep B |
NR |
0 |
0 |
NR |
1 |
0 |
|
Hepatitis C |
NR |
0 |
0 |
NR |
26 |
0 |
|
Hepatitis, Non-A, Non-B |
0 |
0 |
0 |
0 |
5 |
0 |
|
Hepatitis, Other, including unspecified |
0 |
0 |
0 |
0 |
7 |
0 |
|
Lead Poisoning |
9 |
12 |
0 |
7 |
828 |
0 |
|
Legionellosis |
0 |
0 |
0 |
0 |
47 |
0 |
|
Leprosy |
0 |
0 |
0 |
0 |
4 |
0 |
|
Leptospirosis |
0 |
0 |
0 |
0 |
1 |
0 |
|
Listeriosis |
NR |
1 |
0 |
NR |
30 |
0 |
|
Lyme Disease |
0 |
0 |
0 |
0 |
50 |
0 |
|
Malaria |
0 |
1 |
0 |
0.3333 |
76 |
0 |
|
Measles |
0 |
0 |
0 |
0 |
2 |
0 |
|
Meningitis, Group B Strep |
0 |
0 |
0 |
0 |
19 |
0 |
|
Meningitis, List Monocytogenes |
0 |
0 |
0 |
0 |
7 |
0 |
|
Meningitis, Meningococcal |
0 |
1 |
0 |
0.3333 |
45 |
0 |
|
Meningitis, other |
0 |
0 |
0 |
0 |
96 |
0 |
|
Meningitis, Strep Pneumoniae |
0 |
4 |
1 |
1.6667 |
107 |
0 |
|
Meningococcemia, disseminated |
4 |
2 |
0 |
2 |
72 |
0 |
|
Mercury Poisoning |
0 |
0 |
0 |
0 |
10 |
0 |
|
Mumps |
0 |
0 |
0 |
0 |
4 |
0 |
|
Neurotoxic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0 |
|
Pertussis |
0 |
0 |
0 |
0 |
46 |
0 |
|
Pesticide-Related Illness and Injury |
0 |
0 |
0 |
0 |
2 |
0 |
|
Plague, Bubonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Plague, Pneumonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Psittacosis |
0 |
0 |
0 |
0 |
2 |
0 |
|
Q Fever |
NR |
0 |
0 |
NR |
0 |
0 |
|
Human Rabies |
0 |
0 |
0 |
0 |
0 |
0 |
|
Rocky Mountain Spotted Fever |
0 |
0 |
0 |
0 |
2 |
0 |
|
Rubella |
0 |
0 |
0 |
0 |
2 |
0 |
|
Rubella, Congenital |
0 |
0 |
0 |
0 |
1 |
0 |
|
Salmonellosis |
8 |
5 |
1 |
4.6667 |
2599 |
1 |
|
Shigellosis |
5 |
8 |
2 |
5 |
1240 |
0 |
|
Smallpox |
NR |
0 |
0 |
NR |
0 |
0 |
|
Staphylococcus Aureus (GISA/VISA) |
NR |
0 |
0 |
NR |
0 |
0 |
|
Staphylococcus Aureus (GRSA/VRSA) |
NR |
0 |
0 |
NR |
0 |
0 |
|
Streptococcal Disease, Invasive Group A |
0 |
0 |
0 |
0 |
136 |
0 |
|
Streptococcus Pneumoniae, Invasive |
1 |
3 |
3 |
2.3333 |
1082 |
1 |
|
Tetanus |
0 |
0 |
0 |
0 |
1 |
0 |
|
Toxoplasmosis |
0 |
0 |
0 |
0 |
11 |
0 |
|
Trichinosis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Tularemia |
NR |
0 |
0 |
NR |
0 |
0 |
|
Typhoid Fever |
0 |
0 |
0 |
0 |
12 |
0 |
|
Vibrio Alginolyticus |
0 |
0 |
0 |
0 |
14 |
0 |
|
Vibrio Cholerae Type 01 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Vibrio Cholerae Non-01 |
0 |
0 |
0 |
0 |
4 |
0 |
|
Vibrio Fluvialis |
0 |
0 |
0 |
0 |
2 |
0 |
|
Vibrio Hollisae |
0 |
0 |
0 |
0 |
3 |
0 |
|
Vibrio Mimicus |
0 |
0 |
0 |
0 |
2 |
0 |
|
Vibrio, other |
0 |
0 |
0 |
0 |
0 |
0 |
|
Vibrio Parahaemolyticus |
0 |
0 |
0 |
0 |
14 |
0 |
|
Vibrio Vulnificus |
0 |
0 |
0 |
0 |
13 |
0 |
|
Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |